stockrowBrookdale Senior Living Inc.
BKD Healthcare Medical Care Facilities
Brookdale Senior Living Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 2.19% from fiscal 2024.
- Revenue
- −11.6%
- EPS
- +155.6%
- Free cash flow
- +533.1%
- Total debt
- +0.07%
Quarter to June 2026, against a year earlier
Follow BKD
Alert me
Brookdale Senior Living Inc. (BKD) EPS (diluted)
Brookdale Senior Living Inc.'s EPS (diluted) for fiscal 2025 was −$1.12, compared with −$0.89 in fiscal 2024. Over the twelve months to 30 June 2026 it was −$0.58. Over the past ten years it has ranged from −$3.07 (fiscal 2017) to $0.44 (fiscal 2020); the current reading is higher than 64% of that period. Brookdale Senior Living Inc. ranks 37th of 48 Medical Care Facilities companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | −$1.12 | — |
| FY2024 | −$0.89 | — |
| FY2023 | −$0.84 | — |
| FY2022 | −$1.25 | — |
| FY2021 | −$0.54 | — |
| FY2020 | $0.44 | — |
| FY2019 | −$1.44 | — |
| FY2018 | −$2.82 | — |
| FY2017 | −$3.07 | — |
| FY2016 | −$2.18 | — |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $0.10 | — |
| Mar 2026 | −$0.03 | — |
| Dec 2025 | −$0.17 | — |
| Sep 2025 | −$0.48 | — |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| NHC National HealthCare Corporation compare | $7.24 |
| ADUS Addus HomeCare Corporation compare | $6.00 |
| MD Pediatrix Medical Group, Inc. compare | $1.84 |
| AVAH Aveanna Healthcare Holdings Inc. compare | $1.23 |
| GRDN Guardian Pharmacy Services, Inc. compare | $1.03 |
| ASTH Astrana Health, Inc. compare | $0.82 |
| BKD Brookdale Senior Living Inc. | −$0.58 |
| SGRY Surgery Partners, Inc. compare | −$0.70 |
| ACHC Acadia Healthcare Company, Inc. compare | −$12.47 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on BKD
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement